Myriad Genetics Inc. (MYGN) reported first quarter EPS of $0.23 after the close Tuesday, down from 0.41 in the previous year. The consensus estimate was for EPS of $0.25. The company expects to report second quarter EPS of $0.23 to $0.25 and between $1.00 and $1.10 for the full year. Street expectations are for EPS of $0.27 and $1.06.
from RTT - Before the Bell http://ift.tt/2ffroY6
via IFTTT
No comments:
Post a Comment